Provided by Tiger Trade Technology Pte. Ltd.

Alpha Tau Medical

8.42
+1.0313.86%
Pre-market: 8.440.0200+0.24%08:34 EST
Volume:936.79K
Turnover:7.63M
Market Cap:717.92M
PE:-16.13
High:8.60
Open:7.50
Low:7.35
Close:7.40
52wk High:8.60
52wk Low:2.30
Shares:85.26M
Float Shares:57.13M
Volume Ratio:3.31
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5219
EPS(LYR):-0.4540
ROE:-54.38%
ROA:-25.56%
PB:9.25
PE(LYR):-18.54

Loading ...

Alpha Tau Medical Launches U.S. Clinical Trial of Alpha DaRT for Pancreatic Cancer

Reuters
·
Dec 04, 2025

Alpha Tau Medical Wins FDA Approval to Begin Prostate Cancer Trial

Reuters
·
Dec 02, 2025

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients With Locally Recurrent Prostate Cancer

THOMSON REUTERS
·
Dec 02, 2025

Alpha Tau to Participate in December Investor Conferences

GlobeNewswire
·
Dec 01, 2025

Alpha Tau Medical Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow Jones
·
Nov 24, 2025

Promising Developments and Strategic Trials Support Buy Rating for Alpha Tau Medical Ltd.

TIPRANKS
·
Nov 24, 2025

Alpha Tau Medical Reports Q3 2025 Results and Advances in Cancer Therapy

TIPRANKS
·
Nov 21, 2025

Alpha Tau Medical Q3 EPS $(0.14) Misses $(0.12) Estimate

Benzinga
·
Nov 21, 2025

Alpha Tau reports Q3 EPS (32c), consensus (12c)

TIPRANKS
·
Nov 21, 2025

Alpha Tau Medical reports third quarter 2025 financial results

Reuters
·
Nov 21, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 20, 2025

Oramed Pharmaceuticals reports $65 million net income for nine months ended September 2025

Reuters
·
Nov 17, 2025

Alpha Tau to Participate at Jefferies Global Healthcare Conference in London

GlobeNewswire
·
Nov 11, 2025

Alpha Tau Medical Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 22, 2025

Alpha Tau Medical Ltd - Secures Radioactive Material License in New Hampshire

THOMSON REUTERS
·
Oct 21, 2025

Alpha Tau Medical Ltd - Aiming to Produce Alpha Dart Treatments in Hudson Facility in 2026

THOMSON REUTERS
·
Oct 21, 2025

Alpha Tau Medical Secures Radioactive Material License for New Hampshire Manufacturing Facility

Reuters
·
Oct 21, 2025

H.C. Wainwright Sticks to Its Buy Rating for Alpha Tau Medical Ltd (DRTS)

TIPRANKS
·
Sep 19, 2025

Alpha Tau Medical Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 03, 2025

Alpha Tau Medical Ltd. Launches U.S. Multi-Center Clinical Trial for Alpha DaRT in Pancreatic Cancer Treatment

Reuters
·
Sep 02, 2025